BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 778898)

  • 1. Carcinoembryonic antigen and skin test reactivity in tumor radiotherapy.
    Vider M; Kashmiri R; Moses B; Earlywine D; Meeker WR; Utley JF; Maruyama Y
    Radiology; 1976 Jun; 119(3):677-81. PubMed ID: 778898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoembryonic antigen (CEA) monitoring in the management of radiotherapeutic patients.
    Vider M; Kashmiri R; Hunter L; Moses B; Meeker WR; Utley JF; Maruyama Y
    Oncology; 1974; 30(4):257-72. PubMed ID: 4459740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and prognosis in colon cancer based on a profile in immune reactivity.
    Lurie BB; Bull DM; Zamcheck N; Steward AM; Helms RA
    J Natl Cancer Inst; 1975 Feb; 54(2):319-25. PubMed ID: 1113318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The DNCB skin test and its comparison with the radioimmunological determination of CEA in some types of neoplasms].
    Bianucci P; Pastorino G; De Rossi O
    Minerva Med; 1979 May; 70(25):1795-801. PubMed ID: 572515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy.
    Stringou E; Chondros K; Kouvaris J; Kakari S; Papavassiliou K
    Anticancer Res; 1992; 12(1):251-5. PubMed ID: 1567173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic antigen (CEA) monitoring in the management of radiotherapeutic and chemotherapeutic patients.
    Vider M; Kashmin R; Meeker WR; Moses B; Maruyama Y
    Am J Roentgenol Radium Ther Nucl Med; 1975 Aug; 124(4):630-5. PubMed ID: 51593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of carcinoembryonic antigen and a tumor-extracted carcinoembryonic antigen-related antigen in cancer patients.
    Shively JE; Spayth V; Chang FF; Metter GE; Klein L; Presant CA; Todd CW
    Cancer Res; 1982 Jun; 42(6):2506-13. PubMed ID: 7074626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced delayed hypersensitivity skin test reactivity with serial testing in healthy volunteers.
    Keystone EC; Demerieux P; Gladman D; Poplonski L; Piper S; Buchanan R
    Clin Exp Immunol; 1980 Apr; 40(1):202-5. PubMed ID: 6993077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of the DNCB skin test and CEA assay in the prognosis of malignant neoplasms].
    Ciambellotti E; Moro G
    Arch Sci Med (Torino); 1983; 140(3):267-72. PubMed ID: 6675584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
    Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
    Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed-type hypersensitivity skin testing. A review.
    Ahmed AR; Blose DA
    Arch Dermatol; 1983 Nov; 119(11):934-45. PubMed ID: 6639116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma carcinoembryonic antigen (CEA) as an indicator for radical or palliative radiotherapy in patients with rectal cancer.
    Arnott SJ
    Cancer Detect Prev; 1983; 6(1-2):155-9. PubMed ID: 6192917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carcinoembryonic antigen (CEA) in patients with lung cancer: correlation with tumour extent and response to treatment (author's transl)].
    Gropp C; Lehmann FG; Havemann K
    Dtsch Med Wochenschr; 1977 Jul; 102(30):1079-82. PubMed ID: 891388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The epicutaneous DNCB test and CEA determination in neoplasms of the breast, digestive tract, lung and urogenital system].
    Bianucci P; Pastorino G; De Rossi O; Brondi P
    Minerva Med; 1979 Dec; 70(54):3701-4. PubMed ID: 574929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen (CEA) measurements as an aid to management of patients with lung cancer treated by radiotherapy.
    Ahlemann LM; Staab HJ; Koch HL; Anderer FA
    Oncodev Biol Med; 1980; 1(3):143-50. PubMed ID: 7279701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor marker CEA in monitoring of response to tegafur-uracil and folinic acid in patients with metastatic colorectal cancer.
    Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Yen CC; Chen WS; Jiang JK; Yang SH; Wang HS; Chen PM
    Hepatogastroenterology; 2002; 49(44):388-92. PubMed ID: 11995458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue polypeptide antigen and carcinoembryonic antigen in colon tumors: serum levels and immunohistochemical localization.
    Bombardieri E; Jotti GS; Cocciolo MG; Mori M; Rusconi A; Rusca M; Seregni E; Becchi G; Fontanesi M; Tardini A
    Cancer Detect Prev; 1985; 8(1-2):219-26. PubMed ID: 4064041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical use of carcinoembryonic antigen (CEA) determination].
    Mach J
    Bull Cancer; 1975; 62(4):445-52. PubMed ID: 1212528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of a human embryonic antigen complex in studying the immune response in cancer patients].
    Gorodilova VV; Mandrik EV; Ul'chenko VM
    Vopr Onkol; 1982; 28(1):23-7. PubMed ID: 7199781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of carcinoembryonic antigen (CEA) in the diagnosis of malignant tumors of the urogenital tract].
    Rost A; Kneppenberg U; Rost P
    Helv Chir Acta; 1976 Jul; 43(3):271-8. PubMed ID: 947865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.